<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>1985 (3) TMI 254 - CEGAT NEW DELHI</title>
    <link>https://www.taxtmi.com/caselaws?id=167259</link>
    <description>Sodium bisulphite used in the manufacture of analgin was treated as a drug intermediate eligible for duty exemption under the applicable notification. The material showed that it contributed to the structure of the drug rather than merely assisting the chemical reaction, and drug-control certificates together with chemical reference material supported its use as an intermediate. On the cumulative evidence, the exemption claim was upheld in favour of the assessee.</description>
    <language>en-us</language>
    <pubDate>Fri, 29 Mar 1985 00:00:00 +0530</pubDate>
    <lastBuildDate>Sat, 13 Dec 2014 11:09:35 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=370956" rel="self" type="application/rss+xml"/>
    <item>
      <title>1985 (3) TMI 254 - CEGAT NEW DELHI</title>
      <link>https://www.taxtmi.com/caselaws?id=167259</link>
      <description>Sodium bisulphite used in the manufacture of analgin was treated as a drug intermediate eligible for duty exemption under the applicable notification. The material showed that it contributed to the structure of the drug rather than merely assisting the chemical reaction, and drug-control certificates together with chemical reference material supported its use as an intermediate. On the cumulative evidence, the exemption claim was upheld in favour of the assessee.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Fri, 29 Mar 1985 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=167259</guid>
    </item>
  </channel>
</rss>